Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage

BackgroundThere is an urgent need for cost-effective, easy-to-measure biomarkers to identify subjects who will develop Alzheimer’s disease (AD), especially at the pre-symptomatic stage. This stage can be determined in autosomal dominant AD (ADAD) which offers the opportunity to observe the dynamic b...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wei Qin, Fangyu Li, Longfei Jia, Qi Wang, Ying Li, Yiping Wei, Yan Li, Hongmei Jin, Jianping Jia
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-06-01
Colecção:	Frontiers in Aging Neuroscience
Assuntos:	Alzheimer’s disease preclinical stage phosphorylated tau 181 serum biomarker
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fnagi.2022.900773/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!